Emgality is delivered via an initial 240-mg loading dose, followed by 120-mg once-monthly self-injections. Aimovig is administered once monthly
EMGALITY is a drug used for the preventive treatment of migraine in adults. Patients randomized to EMGALITY 120 mg monthly received an initial dose of 240 mg on the first month, followed by
In all three studies, patients were randomized to receive once-monthly placebo, Emgality 120 mg after an initial loading dose of 240 mg, or Emgality 240 mg. The
and 240 mg monthly dosing to 1 year in patients with episodic or chronic migraine. Emgality. [data on file]. October 2024. Emgality
What Is the Recommended Dose of Emgality? The current recommended dose of Emgality for Migraine is one loading dose of 240 mg, then monthly doses of 120 mg
Emgality is delivered via an initial 240-mg loading dose, followed by 120-mg once-monthly self-injections. Aimovig is administered once monthly
The current recommended dose of Emgality for Migraine is one loading dose of 240 mg, then monthly doses of 120 mg thereafter. For episodic
Participants were randomized to receive once-monthly placebo, Emgality 120 mg after an initial loading dose of 240, or Emgality 240 mg. A subset
Emgality is delivered via an initial 240-mg loading dose, followed by 120-mg once-monthly self-injections. Aimovig is administered once monthly
Comments